Analysis
Galderma R&D Adopts Agilent Technologies' Electronic Lab Notebook
Agilent Technologies, Inc. and Galderma R&D today announced that Galderma has adopted the Agilent Electronic Lab Notebook (ELN) to automate scientific data management at its main R&D center, the largest facility of its type devoted to dermatological research and development.
We iElectronic lab notebook systems is a very competitive category and we are extremely pleased that the Galderma team recognized the efficiencies, ease-of-use and high-level of support of the Agilent ELN, said Debra Toburen, Agilent senior product manager, Informatics. This is just the latest example of the rapid growth of the Agilent ELN product line.
The Agilent ELN provides numerous benefits beyond eliminating paper lab notebooks. The open architecture is designed to simplify and accelerate the R&D process by streamlining data capture, speeding data search and retrieval, and eliminating redundant data entry. The system facilitates cross-team collaboration and easily integrates with existing processes and procedures. Agilent ELN contains safeguards for intellectual property and maintains record traceability.
The use of the intrinsic Analytical Request Module (ARM) to manage our analytical workflow will enable us to replace our existing LIMS application, Parigot added. The scope of this initial project will therefore provide an ELN to our chemists and our analysts and trace all the interactions between these two groups.